CASI Pharmaceuticals (CASI) Q4 2024 Earnings

15NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.71
-0.49
-0.27
-0.05

Details

Expected EPS
-0.62
Actual EPS
-0.55
Surprise EPS
0.07
Surprise Percent
+11.29%

Description

CASI Pharmaceuticals (CASI) has reported earnings of -0.55 per share for Q4 2024.

0 Comments

Share your thoughts